Revuz J - Search Results

1

A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome.

Wolkenstein P, Carrière V, Charue D, Bastuji-Garin S, Revuz J, Roujeau JC, Beaune P, Bagot M. Wolkenstein P, et al. Among authors: revuz j. Pharmacogenetics. 1995 Aug;5(4):255-8. doi: 10.1097/00008571-199508000-00011. Pharmacogenetics. 1995. PMID: 8528274 No abstract available.

2

Advances in toxic epidermal necrolysis.

Revuz JE, Roujeau JC. Revuz JE, et al. Semin Cutan Med Surg. 1996 Dec;15(4):258-66. doi: 10.1016/s1085-5629(96)80039-3. Semin Cutan Med Surg. 1996. PMID: 9069594 Review.

3

Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.

Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Assier H, et al. Among authors: revuz j. Arch Dermatol. 1995 May;131(5):539-43. Arch Dermatol. 1995. PMID: 7741539

4

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Wolkenstein P, et al. Among authors: revuz j. Arch Dermatol. 1995 May;131(5):544-51. Arch Dermatol. 1995. PMID: 7741540

5

Evolving pattern of drug-induced toxic epidermal necrolysis.

Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau JC. Correia O, et al. Among authors: revuz j. Dermatology. 1993;186(1):32-7. doi: 10.1159/000247299. Dermatology. 1993. PMID: 8435514

6

Impaired antigen presentation in toxic epidermal necrolysis.

Bagot M, Charue D, Heslan M, Wechsler J, Roujeau JC, Revuz J. Bagot M, et al. Among authors: revuz j. Arch Dermatol. 1993 Jun;129(6):721-7. Arch Dermatol. 1993. PMID: 8507074

7

Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.

Wolkenstein P, Chosidow O, Fléchet ML, Robbiola O, Paul M, Dumé L, Revuz J, Roujeau JC. Wolkenstein P, et al. Among authors: revuz j. Contact Dermatitis. 1996 Oct;35(4):234-6. doi: 10.1111/j.1600-0536.1996.tb02364.x. Contact Dermatitis. 1996. PMID: 8957644

8

Drug-induced toxic epidermal necrolysis.

Wolkenstein PE, Roujeau JC, Revuz J. Wolkenstein PE, et al. Among authors: revuz j. Clin Dermatol. 1998 May-Jun;16(3):399-408. doi: 10.1016/s0738-081x(98)00011-x. Clin Dermatol. 1998. PMID: 9642534 Review. No abstract available.

9

Toxic epidermal necrolysis.

Wolkenstein P, Revuz J. Wolkenstein P, et al. Among authors: revuz j. Dermatol Clin. 2000 Jul;18(3):485-95, ix. doi: 10.1016/s0733-8635(05)70196-0. Dermatol Clin. 2000. PMID: 10943543 Review.

10

Prognostic value of histologic features of toxic epidermal necrolysis.

Valeyrie-Allanore L, Bastuji-Garin S, Guégan S, Ortonne N, Bagot M, Roujeau JC, Revuz JE, Wechsler J, Wolkenstein P. Valeyrie-Allanore L, et al. Among authors: revuz je. J Am Acad Dermatol. 2013 Feb;68(2):e29-35. doi: 10.1016/j.jaad.2011.10.007. Epub 2011 Nov 16. J Am Acad Dermatol. 2013. PMID: 22088428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page